Biologically synthesized silver nanoparticles induce neuronal differentiation of SH-SY5Y cells via modulation of reactive oxygen species, phosphatases, and kinase signaling pathways

Biotechnology Journal

Volumn 9, Issue 7, 2014, Pages 934-943

  Dayem, Ahmed Abdal ^a   Kim, Bongwoo ^a   Gurunathan, Sangiliyandi ^a   Choi, Hye Yeon ^a   Yang, Gwangmo ^a   Saha, Subbroto Kumar ^a   Han, Dawoon ^a   Han, Jihae ^a   Kim, Kyeongseok ^a   Kim, Jin Hoi ^a   Cho, Ssang Goo ^a  

^a Konkuk University   (South Korea)

Author keywords

Dual specificity phosphatases (DUSPs); Neuroblastoma; Neuronal differentiation; Reactive oxygen species; Silver nanoparticles

Indexed keywords

CYTOLOGY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; OXYGEN; PHOSPHATASES; SILVER; STEM CELLS; SYNTHESIS (CHEMICAL);

DUAL-SPECIFICITY PHOSPHATASES (DUSPS); NEUROBLASTOMAS; NEURONAL DIFFERENTIATION; REACTIVE OXYGEN SPECIES; SILVER NANOPARTICLES;

NEURONS;

BETA TUBULIN; BETA TUBULIN III; DUAL SPECIFICITY PHOSPHATASE; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; NEUROGENIN 1; NEUROMODULIN; PROTEIN; PROTEIN DRD2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DOPAMINE 2 RECEPTOR; DRD2 PROTEIN, HUMAN; MAP2 PROTEIN, HUMAN; METAL NANOPARTICLE; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; NEUROG1 PROTEIN, HUMAN; PHOSPHATASE; SILVER; TUBULIN;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOLOGY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DUAL-SPECIFICITY PHOSPHATASES; GAP-43 PROTEIN; HUMANS; METAL NANOPARTICLES; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONS; PHOSPHORIC MONOESTER HYDROLASES; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; SILVER; SYNAPTOPHYSIN; TUBULIN;

EID: 84903765217     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201300555     Document Type: Article

References (80)

1. Agholme, L., Lindstrom, T., Kagedal, K., Marcusson, J., Hallbeck, M., An in vitro model for neuroscience: Differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J. Alzheimers Dis. 2010, 20, 1069-1082.
2. Delfino-Machín, M., Chipperfield, T. R., Rodrigues, F. S. L. M., Kelsh, R. N., The proliferating field of neural crest stem cells. Developmental Dynamics 2007, 236, 3242-3254.
3. Cheung, Y. T., Lau, W. K., Yu, M. S., Lai, C. S. et al., Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. NeuroToxicology 2009, 30, 127-135.
4. Lopes, F. M., Schroder, R., da Frota, M. L. Jr., Zanotto-Filho, A. et al., Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for parkinson disease studies. Brain Res 2010, 1337, 85-94.
5. Constantinescu, R., Constantinescu, A., Reichmann, H., Janetzky, B., Neuronal differentiation and long-term culture of the human neuroblastoma line C, Neuropsychiatric disorders an integrative approach, Springer 2007, pp. 17-28.
6. Yong-Kee, C., Warre, R., Monnier, P., Lozano, A., Nash, J., Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in parkinson's disease. Neurotox. Res. 2012, 22, 355-364.
7. Pahlman, S., Ruusala, A. I., Abrahamsson, L., Mattsson, M. E., Esscher, T., Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbolester-induced differentiation. Cell Differ. 1984, 14, 135-144.
8. Xie, H. R., Hu, L. S., Li, G. Y., SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in parkinson's disease. Chin Med. J. (Engl.) 2010, 123, 1086-1092.
9. Clagett-Dame, M., McNeill, E. M., Muley, P. D., Role of all-trans retinoic acid in neurite outgrowth and axonal elongation. J. Neurobiol. 2006, 66, 739-756.
10. Tosetti, P., Taglietti, V., Toselli, M., Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. J. Neurophysiol. 1998, 79, 648-658.
11. Ciccarone, V., Spengler, B. A., Meyers, M. B., Biedler, J. L., Ross, R. A., Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res. 1989, 49, 219-225.
12. Gimenez-Cassina, A., Lim, F., Diaz-Nido, J., Differentiation of a human neuroblastoma into neuron-like cells increases their susceptibility to transduction by herpesviral vectors. J. Neurosci Res 2006, 84, 755-767.
13. Kovalevich, J., Langford, D., Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology, Neuronal cell culture, Springer 2013, pp. 9-21.
14. Katsetos, C. D., Herman, M. M., Mork, S. J., Class III beta-tubulin in human development and cancer. Cell Motil. Cytoskeleton 2003, 55, 77-96.
15. Biggs, J. E., Lu, V. B., Stebbing, M. J., Balasubramanyan, S., Smith, P. A., Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol. Pain 2010, 6, 44.
16. Wheeler, B. C., Brewer, G. J., Designing neural networks in culture: Experiments are described for controlled growth, of nerve cells taken from rats, in predesigned geometrical patterns on laboratory culture dishes. Proc. IEEE, 98, 398-406.
17. Gilmore, J. L., Yi, X., Quan, L., Kabanov, A. V., Novel nanomaterials for clinical neuroscience. J. Neuroimmune Pharmacol. 2008, 3, 83-94.
18. Quadros, M. E., Marr, L. C., Environmental and human health risks of aerosolized silver nanoparticles. J. Air Waste Manag. Assoc. 2010, 60, 770-781.
19. Bartlomiejczyk, T., Lankoff, A., Kruszewski, M., Szumiel, I., Silver nanoparticles - allies or adversaries? Ann. Agr. Env. Med. 2013, 20, 48-54.
20. Oberdörster, G., Stone, V., Donaldson, K., Toxicology of nanoparticles: A historical perspective. Nanotoxicology 2007, 1, 2-25.
21. Portney, N., Ozkan, M., Nano-oncology: Drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 2006, 384, 620-630.
22. Park, G. E., Webster, T. J., A review of nanotechnology for the development of better orthopedic implants. J. Biomed. Nanotechnol. 2005, 1, 18-29.
23. Sharma, V. K., Yngard, R. A., Lin, Y., Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145, 83-96.
24. Moiemen, N. S., Shale, E., Drysdale, K. J., Smith, G. et al., Acticoat dressings and major burns: Systemic silver absorption. Burns 2011, 37, 27-35.
25. Kim, K.-J., Sung, W. S., Suh, B. K., Moon, S.-K. et al., Antifungal activity and mode of action of silver nano-particles on candida albicans. Biometals 2009, 22, 235-242.
26. Elechiguerra, J. L., Burt, J. L., Morones, J. R., Camacho-Bragado, A. et al., Interaction of silver nanoparticles with hiv-1. J. Nanobiotechnol. 2005, 3, 1-10.
27. Tian, J., Wong, K. K., Ho, C. M., Lok, C. N. et al., Topical delivery of silver nanoparticles promotes wound healing. Chem. Med. Chem. 2007, 2, 129-136.
28. Sung, J. H., Ji, J. H., Park, J. D., Yoon, J. U. et al., Subchronic inhalation toxicity of silver nanoparticles. Toxicological sciences 2009, 108, 452-461.
29. Xu, F., Piett, C., Farkas, S., Qazzaz, M., Syed, N. I., Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol. Brain 2013, 6, 29.
30. Sung, J. H., Ji, J. H., Yoon, J. U., Kim, D. S. et al., Lung function changes in sprague-dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 2008, 20, 567-574.
31. Anil Kumar, S., Abyaneh, M., Gosavi, S. W., Kulkarni, S. et al., Nitrate reductase-mediated synthesis of silver nanoparticles from agno3. Biotechnol Lett 2007, 29, 439-445.
32. Kalimuthu, K., Suresh Babu, R., Venkataraman, D., Bilal, M., Gurunathan, S., Biosynthesis of silver nanocrystals by bacillus licheniformis. Colloids Surf. B 2008, 65, 150-153.
33. Gurunathan, S., Kalishwaralal, K., Vaidyanathan, R., Venkataraman, D. et al., Biosynthesis, purification and characterization of silver nanoparticles using escherichia coli. Colloids Surf. B 2009, 74, 328-335.
34. Sriram, M. I., Kanth, S. B. M., Kalishwaralal, K., Gurunathan, S., Antitumor activity of silver nanoparticles in dalton's lymphoma ascites tumor model. Int. J. Nanomed. 2010, 5, 753.
35. Finkel, T., Holbrook, N. J., Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239-247.
36. Boucher, W., Stern, J. M., Kotsinyan, V., Kempuraj, D. et al., Intravesical nanocrystalline silver decreases experimental bladder inflammation. J. Urol. 2008, 179, 1598-1602.
37. Jennifer, M., Nanoparticle technology as a double-edged sword: Cytotoxic, genotoxic and epigenetic effects on living cells. J. Biomater. Nanobiotechnol. 2013, 4, 53-63.
38. Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., Amidon, G. L., The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharmaceut. Res. 1997, 14, 1568-1573.
39. Osaki, F., Kanamori, T., Sando, S., Sera, T., Aoyama, Y., A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 2004, 126, 6520-6521.
40. Alon, N., Miroshnikov, Y., Perkas, N., Nissan, I. et al., Silver nanoparticles promote neuronal growth. Procedia Eng. 2013, 59, 25-29.
41. Levard, C., Hotze, E. M., Lowry, G. V., Brown, G. E., Environmental transformations of silver nanoparticles: Impact on stability and toxicity. Environ. Sci. Tech. 2012, 46, 6900-6914.
42. Liu, J., Sonshine, D. A., Shervani, S., Hurt, R. H., Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010, 4, 6903-6913.
43. AshaRani, P. V., Low Kah Mun, G., Hande, M. P., Valiyaveettil, S., Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3, 279-290.
44. Choi, O., Hu, Z., Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ. Sci. Tech. 2008, 42, 4583-4588.
45. Braydich-Stolle, L. K., Lucas, B., Schrand, A., Murdock, R. C. et al., Silver nanoparticles disrupt GDNF/fyn kinase signaling in spermatogonial stem cells. Toxicol. Sci. 2010, 116, 577-589.
46. Carlson, C., Hussain, S. M., Schrand, A. M., Braydich-Stolle, L. K. et al., Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112, 13608-13619.
47. Eom, H. J., Choi, J., p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ. Sci. Tech. 2010, 44, 8337-8342.
48. Hsin, Y. H., Chena, C. F., Huang, S., Shih, T. S. et al., The apoptotic effect of nanosilver is mediated by a ROS and JNK-dependent mechanism involving the mitochondrial pathway in nih3t3 cells. Toxicol. Lett. 2008, 179, 130-139.
49. Hussain, S. M., Hess, K. L., Gearhart, J. M., Geiss, K. T., Schlager, J. J., In vitro toxicity of nanoparticles in brl 3a rat liver cells. Toxicol.in vitro 2005, 19, 975-983.
50. Kim, S., Choi, J. E., Choi, J., Chung, K. H. et al., Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. in vitro 2009, 23, 1076-1084.
51. Droge, W., Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95.
52. Hancock, J. T., Desikan, R., Neill, S. J., Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 2001, 29, 345-350.
53. Puceat, M., Role of rac-gtpase and reactive oxygen species in cardiac differentiation of stem cells. Antioxid. Redox Signal. 2005, 7, 1435-1439.
54. Imhoff, B. R., Hansen, J. M., Extracellular redox environments regulate adipocyte differentiation. Differentiation 2010, 80, 31-39.
55. Lee, N. K., Choi, Y. G., Baik, J. Y., Han, S. Y. et al., A crucial role for reactive oxygen species in Rankl-induced osteoclast differentiation. Blood 2005, 106, 852-859.
56. Huang, H., Kim, H. J., Chang, E. J., Lee, Z. H. et al., Il-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: Implications for bone remodeling. Cell Death Differ. 2009, 16, 1332-1343.
57. Tsatmali, M., Walcott, E. C., Makarenkova, H., Crossin, K. L., Reactive oxygen species modulate the differentiation of neurons in clonal cortical cultures. Mol. Cell. Neurosci. 2006, 33, 345-357.
58. Le Belle, J. E., Orozco, N. M., Paucar, A. A., Saxe, J. P. et al., Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a pi3k/akt-dependant manner. Cell stem cell 2011, 8, 59-71.
59. Peunova, N., Enikolopov, G., Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995, 375, 68-73.
60. Katoh, S., Mitsui, Y., Kitani, K., Suzuki, T., Hyperoxia induces the differentiated neuronal phenotype of PC12 cells by producing reactive oxygen species. Biochem. Biophys. Res. Commun. 1997, 241, 347-351.
61. Llansola Portoleìs, M. J., David Gara, P. M., Kotler, M. n. L., Bertolotti, S. et al., Silicon nanoparticle photophysics and singlet oxygen generation. Langmuir 2010, 26, 10953-10960.
62. Misawa, M., Takahashi, J., Generation of reactive oxygen species induced by gold nanoparticles under X-ray and UV irradiations. Nanomedicine 2011, 7, 604-614.
63. Barnard, A. S., Xu, H., An environmentally sensitive phase map of titania nanocrystals. ACS Nano 2008, 2, 2237-2242.
64. Chairuangkitti, P., Lawanprasert, S., Roytrakul, S., Aueviriyavit, S. et al., Silver nanoparticles induce toxicity in A549 cells via ROSs-dependent and ROS-independent pathways. Toxicol. in vitro 2013, 27, 330-338.
65. Kang, K., Lim, D. H., Choi, I. H., Kang, T. et al., Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol. Lett. 2011, 205, 227-234.
66. Goldsmit, Y., Erlich, S., Pinkas-Kramarski, R., Neuregulin induces sustained reactive oxygen species generation to mediate neuronal differentiation. Cell. Mol. Neurobiol. 2001, 21, 753-769.
67. Katoh, S., Mitsui, Y., Kitani, K., Suzuki, T., Hyperoxia induces the neuronal differentiated phenotype of PC12 cells via a sustained activity of mitogen-activated protein kinase induced by Bcl-2. Biochem. J. 1999, 338, 465-470.
68. Fukunaga, K., Miyamoto, E., Role of MAP kinase in neurons. Mol. Neurobiol. 1998, 16, 79-95.
69. Kato, T., Ohtani-Kaneko, R., Ono, K., Okado, N., Shiga, T., Developmental regulation of activated ERK expression in the spinal cord and dorsal root ganglion of the chick embryo. Neurosci. Res. 2005, 52, 11-19.
70. Marshall, C., Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80, 179-185.
71. Selcher, J. C., Atkins, C. M., Trzaskos, J. M., Paylor, R., Sweatt, J. D., A necessity for map kinase activation in mammalian spatial learning. Learn. Mem. 1999, 6, 478-490.
72. Coogan, A. N., O'Leary, D. M., O'Connor, J. J., P42/44 MAP kinase inhibitor pd98059 attenuates multiple forms of synaptic plasticity in rat dentate gyrus in vitro. J. Neurophysiol. 1999, 81, 103-110.
73. Zheng, J., Shen, W. H., Lu, T. J., Zhou, Y. et al., Clathrin-dependent endocytosis is required for Trkb-dependent Akt-mediated neuronal protection and dendritic growth. J. Biol.Chem. 2008, 283, 13280-13288.
74. Lim, C. S., Walikonis, R. S., Hepatocyte growth factor and c-met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal. 2008, 20, 825-835.
75. Tamura, S., Hanada, M., Ohnishi, M., Katsura, K. et al., Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur. J. Biochem. 2002, 269, 1060-1066.
76. Zhang, Z. Y., Protein tyrosine phosphatases: Structure and function, substrate specificity, and inhibitor development. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 209-234.
77. Owens, D. M., Keyse, S. M., Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007, 26, 3203-3213.
78. Cagnol, S., Chambard, J. C., Erk and cell death: Mechanisms of erk-induced cell death-apoptosis, autophagy and senescence. FEBS J. 2010, 277, 2-21.
79. Son, Y., Cheong, Y.-K., Kim, N.-H., Chung, H.-T. et al., Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPk pathways? J. Signal Transduct. 2011, 2011.
80. Karlsson, M., Mathers, J., Dickinson, R. J., Mandl, M., Keyse, S. M., Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase Mkp-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J. Biol. Chem. 2004, 279, 41882-41891.